ArticleCancer genomics & proteomics

Transcriptomic Profiling Identifies Higher DOT1L Expression as a Candidate Biomarker for a Positive Response to Gemcitabine in Cholangiocarcinoma.

Jeng-Shiun DU et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.